Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies
Notified -
Globe Newswire6-01-2026, 16:00
Tata Motors to Acquire Iveco Group 30-07-2025, 22:59
6-01-2026, 16:00
